These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15153777)

  • 1. The role of CD40-CD154 interaction in cell immunoregulation.
    Xu Y; Song G
    J Biomed Sci; 2004; 11(4):426-38. PubMed ID: 15153777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for CD40-directed experimental therapy of human cancer.
    Tong AW; Stone MJ
    Cancer Gene Ther; 2003 Jan; 10(1):1-13. PubMed ID: 12489023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proportion of CD40+ mucosal macrophages is increased in inflammatory bowel disease whereas CD40 ligand (CD154)+ T cells are relatively decreased, suggesting differential modulation of these costimulatory molecules in human gut lamina propria.
    Carlsen HS; Yamanaka T; Scott H; Rugtveit J; Brandtzaeg P
    Inflamm Bowel Dis; 2006 Nov; 12(11):1013-24. PubMed ID: 17075342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD154 (CD40 ligand).
    Schönbeck U; Mach F; Libby P
    Int J Biochem Cell Biol; 2000 Jul; 32(7):687-93. PubMed ID: 10856699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD40/CD154 receptor/ligand dyad.
    Schönbeck U; Libby P
    Cell Mol Life Sci; 2001 Jan; 58(1):4-43. PubMed ID: 11229815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40/CD154 interactions are required for the optimal maturation of skin-derived APCs and the induction of helminth-specific IFN-gamma but not IL-4.
    Hewitson JP; Jenkins GR; Hamblin PA; Mountford AP
    J Immunol; 2006 Sep; 177(5):3209-17. PubMed ID: 16920960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 and CD154 in cell-mediated immunity.
    Grewal IS; Flavell RA
    Annu Rev Immunol; 1998; 16():111-35. PubMed ID: 9597126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo CD40-CD154 (CD40 ligand) interaction induces integrated HIV expression by APC in an HIV-1-transgenic mouse model.
    Chougnet C; Freitag C; Schito M; Thomas EK; Sher A; Shearer GM
    J Immunol; 2001 Mar; 166(5):3210-7. PubMed ID: 11207274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis.
    Lai JH; Luo SF; Ho LJ
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 and autoimmunity: the dark side of a great activator.
    Peters AL; Stunz LL; Bishop GA
    Semin Immunol; 2009 Oct; 21(5):293-300. PubMed ID: 19595612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cells in the pathogenesis of systemic lupus erythematosus: potential roles of CD154-CD40 interactions and costimulatory molecules.
    Yellin MJ; Thienel U
    Curr Rheumatol Rep; 2000 Feb; 2(1):24-31. PubMed ID: 11123036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential requirement for the CD40-CD154 costimulatory pathway during Th cell priming by CD8 alpha+ and CD8 alpha- murine dendritic cell subsets.
    Yasumi T; Katamura K; Yoshioka T; Meguro TA; Nishikomori R; Heike T; Inobe M; Kon S; Uede T; Nakahata T
    J Immunol; 2004 Apr; 172(8):4826-33. PubMed ID: 15067060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance.
    Pinelli DF; Ford ML
    Immunotherapy; 2015; 7(4):399-410. PubMed ID: 25917630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suramin inhibits the CD40-CD154 costimulatory interaction: a possible mechanism for immunosuppressive effects.
    Margolles-Clark E; Jacques-Silva MC; Ganesan L; Umland O; Kenyon NS; Ricordi C; Berggren PO; Buchwald P
    Biochem Pharmacol; 2009 Apr; 77(7):1236-45. PubMed ID: 19283894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation.
    Shepherd DM; Kerkvliet NI
    J Immunol; 1999 Sep; 163(5):2470-7. PubMed ID: 10452982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction: role of memory B cells and CD5+ B cells.
    Blanca IR; Bere EW; Young HA; Ortaldo JR
    J Immunol; 2001 Dec; 167(11):6132-9. PubMed ID: 11714772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD154-CD40-independent up-regulation of B7-2 on splenic antigen-presenting cells and efficient T cell priming by staphylococcal enterotoxin A.
    Eshima K; Choi Y; Flavell RA
    Int Immunol; 2003 Jul; 15(7):817-26. PubMed ID: 12807820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on CD40 and CD154 blockade in transplant models.
    Zhang T; Pierson RN; Azimzadeh AM
    Immunotherapy; 2015; 7(8):899-911. PubMed ID: 26268734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Involvement of CD40-CD154 interaction in immunopathogenesis of collagen diseases and its application to a novel therapeutic strategy].
    Harigai M
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Dec; 27(6):379-88. PubMed ID: 15678891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders.
    Chand Dakal T; Dhabhai B; Agarwal D; Gupta R; Nagda G; Meena AR; Dhakar R; Menon A; Mathur R; Mona ; Yadav V; Sharma A
    Immunobiology; 2020 Mar; 225(2):151899. PubMed ID: 31899051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.